Topic
5 research guides on t3 sourcing & access.
A realistic country-by-country look at customs handling of liothyronine shipments: which borders are strict, why the United States is markedly more lenient than Canada, Australia or the UK, what actually happens when a parcel is stopped, and why plain-label packaging is standard for international research shipments.
What to do after a specialist declines liothyronine: how to read the refusal, how to find a clinician who manages T3 routinely, exactly what to bring to the second appointment, and how to tell when further appointments are no longer worth booking.
A direct answer on whether liothyronine can be bought over the counter, how access differs between the US, UK, Canada, Australia and the EU, why T3 is regulated more tightly than most thyroid medication, and what no-prescription sellers are actually offering.
Liothyronine is prescription-only in most of the world. This is a straight look at what that means in practice, which routes shorten the path to a legitimate prescription, what the research-use-only channel actually is, and how to judge quality on anything sourced outside a pharmacy.
Why most physicians decline to prescribe liothyronine (T3), what the guidelines actually say versus how they get applied in practice, the DIO2 evidence that complicates a flat refusal, and the practical routes available when the answer stays no.